CSL Limited (ASX:CSL) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $206.78 and traded as low as $229.27. CSL shares last traded at $230.69, with a volume of 708,829 shares trading hands.

The business has a 50-day simple moving average of A$226.24 and a two-hundred day simple moving average of A$206.99. The company has a market cap of $104.53 billion and a price-to-earnings ratio of 54.59. The company has a quick ratio of 1.09, a current ratio of 2.53 and a debt-to-equity ratio of 88.79.

The business also recently declared a Final dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, October 11th will be given a $1.478 dividend. The ex-dividend date of this dividend is Tuesday, September 10th. This represents a dividend yield of 0.65%. CSL’s dividend payout ratio is currently 70.04%.

In related news, insider Robert Cuthbertson purchased 6,743 shares of CSL stock in a transaction on Tuesday, August 27th. The stock was bought at an average price of A$234.05 ($165.99) per share, with a total value of A$1,578,199.15 ($1,119,290.18). Also, insider Brian McNamee 692 shares of the firm’s stock in a transaction dated Thursday, August 22nd.

CSL Company Profile (ASX:CSL)

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders.

Featured Story: What is a closed-end mutual fund (CEF)?

Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.